VANDA PHARMACEUTICALS INC. Accrued Employee Benefits, Current
VANDA PHARMACEUTICALS INC. (VNDA) had Accrued Employee Benefits, Current of $127.00 thousand as of 2012-12-31, per its 10-K filed 2013-02-26.
Discontinued › Notes › Payables and Accruals › Accrued Liabilities, Current
us-gaap:AccruedEmployeeBenefitsCurrent · last filed 2013-02-26
- 2012-12-31: Accrued Employee Benefits, Current $127.00K.
- 2012-09-30: Accrued Employee Benefits, Current $931.00K.
- 2012-06-30: Accrued Employee Benefits, Current $744.00K.
- 2011-12-31: Accrued Employee Benefits, Current $100.00K.
| Period end | Accrued Employee Benefits, Current |
|---|---|
| 2012-12-31 | $127.00K 10-K · filed 2013-02-26 |
| 2012-09-30 | $931.00K 10-Q · filed 2012-11-08 |
| 2012-06-30 | $744.00K 10-Q · filed 2012-08-03 |
| 2011-12-31 | $100.00K 10-K · filed 2013-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |